If you would like to find out more about the study or register your ... Contact phone number: Email: ... Alternatively f
Who are the GP-OSMOTIC study investigators? Associate Professor John Furler, Professor James Best (Nanyang Technological University, Singapore), Associate Professor David O’Neal, Professor Jane Speight (Deakin University), Associate Professor Irene Blackberry (La Trobe University), Professor Kamlesh Khunti (University of Leicester, UK), Doctor Kim Dalziel, Professor Danny Liew (Monash University), Clinical Associate Professor Mark Kennedy, Professor Philip Clarke, Clinical Associate Professor Ralph Audehm, Professor Alicia Jenkins (University of Sydney)
How can I find out more?
GP-OSMOTIC is funded by the National Health and Medical Research Council (NHMRC No: 1104241)
If you would like to find out more about the study or register your interest in participating please contact Associate Professor John Furler using the contact details below T: +61 3 8344 4747 M: 0419 393 156 E:
[email protected] Alternatively fax your name and contact details to 9347 6136 My contact details: Name: Contact phone number:
GP-OSMOTIC:
Email: Practice location: Best time to call:
To register online please go to: http://mdhs.unimelb.edu.au/mms/gp/gp-osmotic-study
The University of Melbourne Department of General Practice 200 Berkeley St, Carlton, VIC 3053 www.gp.unimelb.edu.au
A new way to help you and your patients with type 2 diabetes take charge.
The GP-OSMOTIC study is exploring the future in type 2 diabetes management – Continuous Glucose Monitoring (CGM) GP-OSMOTIC MEANS GENERAL PRACTICE OPTIMISING STRUCTURED MONITORING TO IMPROVE CLINICAL OUTCOMES IN TYPE 2 DIABETES
B
eing a part of the study will allow you and your patients to try this new technology that provides a powerful tool for observing blood glucose patterns clearly and in more detail than ever before to guide rational treatment choices to improve glycaemic control. GP-OSMOTIC is led by the Department of General Practice at the University of Melbourne and is funded by the Australian National Health and Medical Research Council.
What is CGM?
Privacy and confidentiality
CGM represents a new way of blood glucose monitoring in type 2 diabetes. Reducing the burden on patients and providing reliable and meaningful data CGM can empower you and your patients to make progress to optimal glycaemic levels, improving their health and reducing the risk of complications.
Our research is conducted according to the principles of Good Clinical Practice and the NHMRC’s National Statement on Ethical Conduct in Human Research.
What is involved in joining the study? GPs who join the study will be trained in how to use a CGM in their routine management of people with type 2 diabetes. Being part of the study will integrate seamlessly with your regular clinical care.
All data collected as part of the study is stored on password protected computers at the Department of General Practice, University of Melbourne and only accessed by the research team.
Our research team will support you and your practice staff to identify and arrange follow up with patients appropriate to use this technology. RACGP QICPD points and a small financial reimbursement are also provided.
GP-OSMOTIC:
